XML 38 R29.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2016
Equity [Abstract]  
Schedule of outstanding warrants

    2015     2016  
    Shares     Weighted
average
exercise
price
    Weighted
average
remaining
life-Years
    Shares     Weighted
average
exercise
price
    Weighted
average
remaining
life-Years
 
                                     
Outstanding: beginning of the year     545,294     $ 1.13       5.9       1,217,941     $ 0.35       4.9  
Granted during the year     675,000     $ 0.07               2,450,000     $ 0.05       6.0  
Cancelled or forfeited     (2,353 )   $ 102.00               (2,450,000 )   $ -       -  
                                                 
Warrants outstanding: end of year     1,217,941     $ 0.35       4.9       1,217,941     $ 0.35       3.9  
                                                 
Warrants exercisable: end of year     1,217,941     $ 0.35       4.9       1,217,941     $ 0.35       3.9  
Schedule of liquidation preference stock

The Series E Preferred stock has a liquidation preference of $1,023,599 as follows:

 

Shares  outstanding     28,500  
         
Face value per share   $ 35  
         
Total face value     997,500  
         
Accrued dividends     26,099  
         
Liquidation preference at December 31, 2016   $ 1,023,599  
Schedule of employee stock compensation expense

A summary of the status of outstanding incentive stock plans is presented below:

 

    2016     2015  
    Shares     Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Life-years
    Shares     Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Life-years
 
Outstanding beginning of year     1,099     $ 2.008       2.53       2,363     $ 2.008       3.53  
Granted during the year     -                       -                  
Cancelled or forfeited     ( )   $                 (1,264                
Options outstanding end of year     1,099     $ 2.008       1.53       1,099     $ 1,070       2.53  
Options exercisable end of year     1,099     $ 2.008       1.05       1,099     $ 1,070       2.53